11 min
Keeping up with the Times: Can Urine Drug Screens be Effective in an Ever Changing Landscape? The MagMutual Podcast
-
- Health & Fitness
In this episode, Steve Adubato, PhD, speaks with Christopher Holstege, MD, chief of the division of medical toxicology and professor of emergency medicine and pediatrics at the University of Virginia and a member of the medical faculty at MagMutual. Dr. Holstege provides important information about urine drug screens, including their history, their ability to keep up with the latest synthetic drugs, whether they can be beat, and what additional testing may be necessary in acute overdose situations. Dr. Holstege also discusses the recent policy changes coming from the DEA on the X-Waiver program for prescribing buprenorphine.
This podcast was originally a production of MDAdvantage, which is now part of the MagMutual family of companies.
In this episode, Steve Adubato, PhD, speaks with Christopher Holstege, MD, chief of the division of medical toxicology and professor of emergency medicine and pediatrics at the University of Virginia and a member of the medical faculty at MagMutual. Dr. Holstege provides important information about urine drug screens, including their history, their ability to keep up with the latest synthetic drugs, whether they can be beat, and what additional testing may be necessary in acute overdose situations. Dr. Holstege also discusses the recent policy changes coming from the DEA on the X-Waiver program for prescribing buprenorphine.
This podcast was originally a production of MDAdvantage, which is now part of the MagMutual family of companies.
11 min